Ferndale Healthcare Supports The Colon Cancer Alliance With RectiCare Partnership

FERNDALE, Mich., March 17, 2015 /PRNewswire/ -- Ferndale Healthcare^®, Inc., has announced a continuation of its partnership with the Colon Cancer Alliance, (www.ccalliance.org) on behalf of its RectiCare^® (Lidocaine 5%) Anorectal Cream brand. The Colon Cancer Alliance, a not-for-profit corporation, is the nation's leading patient advocacy organization dedicated to increasing colon cancer screening rates and survivorship.

"As one of the leading brands designed to manage the symptoms of benign anorectal conditions, we feel a responsibility to partner with an organization, such as the Colon Cancer Alliance, whose sole mission is to raise awareness of colon cancer among consumers of all ages, alerting them to signs and symptoms of the third most prevalent cancer in the United States," said Katherine Gunn, Product Manager for RectiCare^®. "Early detection is key to treating colon cancer and we want to do our part to help reduce its incidence in this country."

One of the ways in which Ferndale Healthcare will be helping to raise awareness is with a patient educational brochure that is being distributed to 2,500 colo-rectal surgery offices nationwide. Called "Colon Cancer Quick Facts," this brochure provides an easy-to-read summary of Signs, Symptoms, and Screening information and statistics, which call out the fact that one in 20 people, male and female, will develop colon cancer in their lifetime. The company hopes that raising awareness with a "quick read," may help motivate women and men to get screened for this type of cancer. The company also petitioned the Governor of Michigan, Rick Snyder, to proclaim March as Colon Cancer Awareness Month.

RectiCare^® is designed to manage the symptoms of benign anorectal conditions, helping to soothe and calm discomfort and pain. RectiCare^® is a topical, local anesthetic cream, which contains the highest lidocaine strength available without a prescription. It is recommended by colon and rectal surgeons nationwide and works quickly to help relieve pain, itching and burning associated with hemorrhoids and other anorectal disorders. For more information, please visit: www.recticare.com or www.ferndalehealthcare.com.

About Ferndale Healthcare^®, Inc.:
Ferndale Healthcare^®, Inc. is an affiliate of Ferndale Pharma Group Inc., a fully integrated holding company. Ferndale Healthcare^® targets several key specialty markets which encompass disease states that range from benign anorectal disorders to various skin conditions. The company's mission is to provide high-quality, value-added products that help patients get back to what matters most in their livesliving well. Many of Ferndale Healthcare's products are leaders in their respective categories.

About The Colon Cancer Alliance:
The Colon Cancer Alliance, Inc. is a not-for-profit 501(c)3 corporation (EIN 86-0947831). The Colon Cancer Alliance's mission is to knock colon cancer out of the top three cancer killers. This mission is being accomplished by championing prevention, funding cutting-edge research and providing the highest quality patient support services. Learn more at ccalliance.org.

MEDIA CONTACT:
Anneka Ranpuria
The Lane Communications Group
212.757.6880
aranpuria@thelcgroup.com

Photo - http://photos.prnewswire.com/prnh/20150316/181971

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ferndale-healthcare-supports-the-colon-cancer-alliance-with-recticare-partnership-300051051.html

SOURCE Ferndale Healthcare, Inc.